Thanyapura Sports and Health Resort, Phuket has partnered with StemCells21 (SC21), a medical biotech company based in Bangkok, Thailand. With over a decade of clinical history and 100 years of collective team experience, SC21 combines 21st-century cellular medicine and cutting-edge supportive therapies to offer the highest quality stem cell treatments with Mesenchymal Stem Cells (MSCs) and Induced Pluripotent Stem Cells (iPSCs).
A first of its kind for Phuket, Thanyapura in partnership with SC21, will offer premium stem cell treatments for various degenerative diseases, immune disorders, injuries and anti-ageing. The treatments can also tackle a host of medical problems such as type 2 diabetes, osteoarthritis, chronic back pain and inflammatory lung diseases such as asthma and bronchitis, as well as strengthen body immunity and improve fertility.
In the sporting world, regenerative medicine is seen as a crucial component and can aid in optimising the human body to perform at a higher level, as well as being highly effective in the treatment of sports injuries through faster healing, reduced injury inflammation and the regeneration of injured tissue. The human-based regenerative therapy has been successful with high calibre athletes for endurance enhancement and lengthening professional careers by reducing injury rates.
Guests can book a free dedicated one-on-one consultation with a certified stem cell specialist for their first session. Those seeking longer-term treatments can book a discounted stay at Thanyapura to utilise its world-class facilities, award-winning vegan and vegetarian restaurants and lifestyle clinic.
Speaking about the new venture, President & CEO of Thanyapura World, Philipp Graf von Hardenberg said, “We are excited to be working with SC21 to facilitate their first clinic outside of Bangkok and deliver world-class treatment to guests and members at Thanyapura. This partnership really supports in putting us on the global stage as a leading lifestyle optimisation destination in the sports and lifestyle industry.”
Treatment packages can be customised from the number of Premium Grade (P1) MSCs to the treatment duration and include supportive therapies from a comprehensive health check-up to the highest standards of after-care services. Thanyapura’s 360 approach will help in delivering better, longer-lasting outcomes for challenging conditions that conventional therapies often fail to address, such as stopping disease progression, as well as avoiding surgical intervention.
“Stem cell therapy is a tool to optimise the human body to perform at a higher level, and we want to make the environment of the body less hazardous and more harmonious for repair and regeneration,” said Paul Collier, Founder and Managing Partner of SC21. “SC21 was founded to provide treatments that few people know are available, and to offer health outcomes that are superior to what most thought possible, and we are looking forward to bringing our experience and expertise to Thanyapura.”
Thanyapura will host a free interactive seminar with stem cell specialists from SC21 on Friday, 30 October 2020 at 11am (GMT + 7). The event, which will also be streamed live and recorded on Facebook, offers a chance for audiences to gain first-hand knowledge and a deeper understanding of stem cells treatments from experts in the field.
